Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder
Atef, A., Bedeer, A. (2021). Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder. EKB Journal Management System, 5(2), 111-122. doi: 10.21608/jcbr.2020.46899.1084
Aliaa Atef; Asmaa Bedeer. "Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder". EKB Journal Management System, 5, 2, 2021, 111-122. doi: 10.21608/jcbr.2020.46899.1084
Atef, A., Bedeer, A. (2021). 'Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder', EKB Journal Management System, 5(2), pp. 111-122. doi: 10.21608/jcbr.2020.46899.1084
Atef, A., Bedeer, A. Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder. EKB Journal Management System, 2021; 5(2): 111-122. doi: 10.21608/jcbr.2020.46899.1084